PUBLISHED: 2017
CATEGORY: Health care providers
TYPE: External Link Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
This statement reviews evidence for a 2-dose immunization schedule of the HPV9 vaccine, and provides recommendations; it summarizes evidence from a recent NACI Literature Review on the use of HPV vaccines in immunocompromised populations, and provides recommendations for HPV vaccine use in these groups.
Corporate Authors: National Advisory Committee on Immunization
Publisher: Publisher
Public Health Agency of Canada